Ubs Group Ag Milestone Pharmaceuticals Inc. Transaction History

Ubs Group Ag

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$1.4 - $2.2 $3,665 - $5,759	2,618 New	2,618 $4,000
Q3 2023 Nov 09, 2023	SELL	$2.68 - $3.69 $4,405 - $6,066	-1,644 Reduced 49.27%	1,693 $5,000
Q2 2023 Aug 11, 2023	BUY	$2.85 - $4.4 $1,610 - $2,486	565 Added 20.38%	3,337 $9,000
Q1 2023 May 12, 2023	SELL	$3.14 - $4.2 $7,576 - $10,134	-2,413 Reduced 46.54%	2,772 $10,000
Q4 2022 Feb 08, 2023	BUY	$3.53 - $9.5 $6,583 - $17,717	1,865 Added 56.17%	5,185 $20,000
Q3 2022 Nov 10, 2022	BUY	$5.86 - $9.43 $13,501 - $21,726	2,304 Added 226.77%	3,320 $31,000
Q2 2022 Aug 10, 2022	BUY	$5.13 - $7.37 $5,212 - $7,487	1,016 New	1,016 $6,000
Q1 2022 May 16, 2022	SELL	$4.1 - $8.24 $4,227 - $8,495	-1,031 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$5.47 - $7.13 $5,639 - $7,351	1,031 New	1,031 $7,000
Q3 2021 Nov 15, 2021	SELL	$5.28 - $6.29 $2,550 - $3,038	-483 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$5.22 - $6.11 $67,943 - $79,527	-13,016 Reduced 96.42%	483 $3,000
Q1 2021 May 12, 2021	SELL	$5.79 - $8.85 $6,641 - $10,150	-1,147 Reduced 7.83%	13,499 $78,000
Q4 2020 Feb 11, 2021	SELL	$5.57 - $7.66 $10,660 - $14,661	-1,914 Reduced 11.56%	14,646 $98,000
Q3 2020 Nov 12, 2020	BUY	$3.34 - $9.8 $10,223 - $29,997	3,061 Added 22.68%	16,560 $121,000
Q1 2020 May 01, 2020	BUY	$1.7 - $22.5 $22,948 - $303,727	13,499 New	13,499 $25,000

28.7M

200

Ticker MIST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,010,900
Market Cap $54M
Description
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.